Desensitisation of native and recombinant human urotensin-II receptors
Autor: | Batuwangala, M., Calo, G., Guerrini, R., L. L., Ng, Mcdonald, J., Lambert, D. G. |
---|---|
Rok vydání: | 2009 |
Předmět: |
Adult
Lipopolysaccharides Urotensin II medicine.medical_specialty Carbachol Urotensins Peptide binding Stimulation Urotensin-II receptor Biology Peripheral blood mononuclear cell Cell Line Receptors G-Protein-Coupled Cell Line Tumor Internal medicine Rhabdomyosarcoma medicine Humans Calcium Signaling RNA Messenger Urotensin II receptor Receptor Desensitisation Pharmacology HEK 293 cells General Medicine Middle Aged Recombinant Proteins Polymerase chain reaction Endocrinology Cell culture Peripheral blood mononuclear cells Calcium Leukocytes Mononuclear medicine.drug |
Zdroj: | Naunyn-Schmiedeberg's Archives of Pharmacology. 380:451-457 |
ISSN: | 1432-1912 0028-1298 |
DOI: | 10.1007/s00210-009-0441-9 |
Popis: | Human urotensin-II (U-II) is an 11-amino-acid cyclic peptide that activates a G(q)-coupled receptor named UT. Little is known about the desensitisation profile of this receptor as peptide binding is essentially irreversible. In the present study, we have examined the effects of U-II and carbachol on Ca(2+) signalling in SJCRH30 rhabdomyosarcoma (receptor density, B(max) approximately 0.1 pmol/mg protein) and human embroynic kidney (HEK)(hUT) (B(max) approximately 1.4 pmol/mg protein) cells expressing native and recombinant UT, respectively. In SJCRH30, HEK(hUT) and human peripheral blood mononuclear cells induced to express native UT by treatment with 2 microg/ml lipopolysaccharide (LPS), we have measured the effects of U-II treatment on UT mRNA. In SJCRH30 cells, primary stimulation with carbachol (250 microM) did not affect a secondary challenge with U-II (1 microM) and primary challenge with U-II did not affect a secondary challenge with carbachol. In contrast, in HEK(hUT) cells, primary stimulation with carbachol (250 microM) reduced a secondary challenge to U-II (1 microM) by 84% and primary challenge with U-II reduced a secondary challenge to carbachol by 76%. Pre-treatment of SJCRH30 cells with U-II reduced UT mRNA after 6 h and this returned to basal after 24 h. In recombinant HEK(hUT) cells, UT mRNA expression increased following a 6 h treatment with 1 microM U-II. U-II treatment of naïve un-stimulated peripheral blood mononuclear cells was without effect. However, when UT expression is up-regulated following 15 h of LPS treatment, a 6 h U-II challenge reduced UT mRNA by 66%. In summary, we report differences in the desensitisation profiles of native and recombinant U-II receptors. Design and interpretation of functional experiments are hampered by irreversibility of U-II binding. |
Databáze: | OpenAIRE |
Externí odkaz: |